You have 9 free searches left this month | for more free features.

Hormone Receptor-positive/HER2-negative Breast Cancer (1)

Non-small Cell Lung Cancer (1)

Squamous Cell Carcinoma of Head and Neck (1)

Triple Negative Breast Cancer (1)

Urothelial Carcinoma (1)

Withdrawn (1)

phase 1/phase 2 (1)

Silverback Therapeutics (1)

pembrolizumab (1)

sbt6290 (1)

drug (1)

Industry (1)

Interventional (1)

sbt6290

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

Apr 4, 2022